Aegerion To Plead Guilty, Pay $40M To Settle Justice, SEC Investigations

Mealey's (May 13, 2016, 10:07 AM EDT) -- CAMBRIDGE, Mass. — Aegerion Pharmaceuticals Inc. on May 12 said in a press release that it will plead guilty to federal misdemeanor violations and pay about $40 million to settle investigations by the U.S. Department of Justice and the Securities and Exchange Commission into its sales activities related to the marketing of its cholesterol drug Juxtapid....